Literature DB >> 20433033

Trends in tuberculosis mortality in the United States, 1990-2006: a population-based case-control study.

Richard S Jung1, Jonathan R Bennion, Frank Sorvillo, Amy Bellomy.   

Abstract

OBJECTIVE: We assessed demographic and temporal trends of tuberculosis (TB)-related deaths in the United States and examined associated comorbidities listed on death certificates.
METHODS: We analyzed TB-related mortality from 1990 through 2006 by examining multiple-cause-of-death data from the National Center for Health Statistics. We assessed age-adjusted mortality rates, secular trends, associations with demographic variables, and comorbid conditions.
RESULTS: From 1990 through 2006, TB was reported as a cause of death among 53,505 people in the U.S. with a combined overall mean age-adjusted mortality rate of 1.16 per 100,000 person-years. The age-adjusted TB mortality rate declined from 2.22 per 100,000 person-years in 1990 to 0.47 per 100,000 person-years in 2006, demonstrating mean annual decline of about 10%. People aged 75 years and older; males; foreign-born people; and those of Hispanic, Asian, black, and Native American race/ethnicity had comparatively elevated TB-related mortality rates. The mortality rate in foreign-born people was more than two times higher than in U.S.-born people. About 89% of deaths among people of Asian race/ethnicity and nearly 50% among black people were foreign-born individuals. Human immunodeficiency virus and selected autoimmune diseases were more common in TB-related deaths.
CONCLUSIONS: TB mortality decreased substantially from 1990 through 2006, but remains an important cause of preventable mortality. The observed decrease was more pronounced among U.S.-born people than among foreign-born people. Disparities in TB-related mortality and the identification of important comorbid conditions can inform strategies targeting subpopulations at increased risk for fatal TB infection.

Entities:  

Mesh:

Year:  2010        PMID: 20433033      PMCID: PMC2848263          DOI: 10.1177/003335491012500307

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  21 in total

Review 1.  The ever-expanding association between rheumatologic diseases and tuberculosis.

Authors:  Carlos Franco-Paredes; Alejandro Díaz-Borjon; Mark A Senger; Lorena Barragan; Michael Leonard
Journal:  Am J Med       Date:  2006-06       Impact factor: 4.965

2.  National trends in the concurrence of tuberculosis and acquired immunodeficiency syndrome.

Authors:  D R Burwen; A B Bloch; L D Griffin; C A Ciesielski; H A Stern; I M Onorato
Journal:  Arch Intern Med       Date:  1995-06-26

3.  Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group.

Authors:  N Markowitz; N I Hansen; P C Hopewell; J Glassroth; P A Kvale; B T Mangura; T C Wilcosky; J M Wallace; M J Rosen; L B Reichman
Journal:  Ann Intern Med       Date:  1997-01-15       Impact factor: 25.391

4.  Tuberculosis mortality associated with AIDS and drug or alcohol abuse: analysis of multiple cause-of-death data.

Authors:  M C White; C J Portillo
Journal:  Public Health       Date:  1996-05       Impact factor: 2.427

5.  Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.

Authors:  Diane E Bennett; Jeanne M Courval; Ida Onorato; Tracy Agerton; Judy D Gibson; Lauren Lambert; Geraldine M McQuillan; Brenda Lewis; Thomas R Navin; Kenneth G Castro
Journal:  Am J Respir Crit Care Med       Date:  2007-11-07       Impact factor: 21.405

6.  The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis.

Authors:  V K Rao; E P Iademarco; V J Fraser; M H Kollef
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

7.  Trends in tuberculosis--United States, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-03-21       Impact factor: 17.586

8.  Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004.

Authors:  Rachel Albalak; Richard J O'Brien; J Steve Kammerer; Sean M O'Brien; Suzanne M Marks; Kenneth G Castro; Marisa Moore
Journal:  Arch Intern Med       Date:  2007-12-10

9.  Tuberculosis, AIDS, and death among substance abusers on welfare in New York City.

Authors:  L N Friedman; M T Williams; T P Singh; T R Frieden
Journal:  N Engl J Med       Date:  1996-03-28       Impact factor: 91.245

10.  The fall after the rise: Tuberculosis in the United States, 1991 through 1994.

Authors:  M T McKenna; E McCray; J L Jones; I M Onorato; K G Castro
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

View more
  8 in total

Review 1.  Burden of tuberculosis in indigenous peoples globally: a systematic review.

Authors:  D Tollefson; E Bloss; A Fanning; J T Redd; K Barker; E McCray
Journal:  Int J Tuberc Lung Dis       Date:  2013-07-02       Impact factor: 2.373

2.  Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children.

Authors:  Benjamin L Laskin; Jens Goebel; Jeffrey R Starke; Daniel P Schauer; Mark H Eckman
Journal:  Am J Kidney Dis       Date:  2012-07-10       Impact factor: 8.860

Review 3.  A narrative review of tuberculosis in the United States among persons aged 65 years and older.

Authors:  Iris L Wu; Amit S Chitnis; Devan Jaganath
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2022-06-13

4.  Death with tuberculosis in california, 1994-2008.

Authors:  Lisa Pascopella; Pennan M Barry; Jennifer Flood; Kathryn DeRiemer
Journal:  Open Forum Infect Dis       Date:  2014-10-01       Impact factor: 3.835

5.  Spatial analysis of deaths from pulmonary tuberculosis in the city of São Luís, Brazil.

Authors:  Marcelino Santos-Neto; Mellina Yamamura; Maria Concebida da Cunha Garcia; Marcela Paschoal Popolin; Tatiane Ramos Dos Santos Silveira; Ricardo Alexandre Arcêncio
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

6.  Association of Pulmonary Tuberculosis and Diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000-2012.

Authors:  Guadalupe Delgado-Sánchez; Lourdes García-García; Martín Castellanos-Joya; Pablo Cruz-Hervert; Leticia Ferreyra-Reyes; Elizabeth Ferreira-Guerrero; Andrés Hernández; Victor Manuel Ortega-Baeza; Rogelio Montero-Campos; José Antonio Sulca; Ma de Lourdes Martínez-Olivares; Norma Mongua-Rodríguez; Renata Baez-Saldaña; Jesús Felipe González-Roldán; Hugo López-Gatell; Alfredo Ponce-de-León; José Sifuentes-Osornio; María Eugenia Jiménez-Corona
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 7.  Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs.

Authors:  Juan M Cubillos-Angulo; Betânia M F Nogueira; María B Arriaga; Beatriz Barreto-Duarte; Mariana Araújo-Pereira; Catarina D Fernandes; Caian L Vinhaes; Klauss Villalva-Serra; Vanessa M Nunes; João P Miguez-Pinto; Eduardo P Amaral; Bruno B Andrade
Journal:  Front Med (Lausanne)       Date:  2022-09-23

8.  Will the European Union reach the United Nations Millennium declaration target of a 50% reduction of tuberculosis mortality between 1990 and 2015?

Authors:  Marieke J van der Werf; Sandro Bonfigli; Frantiska Hruba
Journal:  BMC Public Health       Date:  2017-07-06       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.